logo-loader
viewBioLargo, Inc.

BioLargo says interest is 'extreme' in its Clyraguard spray that dispels the coronavirus

BioLargo Inc (OTCQB:BLGO) CEO Dennis Calvert tells Proactive that Clyraguard, a spray developed by its subsidiary Clyra Medical Technologies, was shown to cause complete inactivation of the coronavirus in lab testing.

Calvert says Clyraguard is a personal protective spray designed to help frontline healthcare workers prevent cross-contamination of their personal protective equipment from the coronavirus.

Quick facts: BioLargo, Inc.

Price: 0.165 USD

OTCMKTS:BLGO
Market: OTCQB
Market Cap: $29.22 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of BioLargo, Inc. named herein, including the promotion by the Company of BioLargo, Inc. in any Content on the Site, the Company receives from...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Botswana Diamonds' James Campbell hails recovery of macro diamonds from...

Botswana Diamonds PLC's (LON:BOD) James Campbell caught up with Proactive London's Andrew Scott following the news they've recovered macro diamonds from the processing of two bulk samples taken from the Marsfontein diamond development project in South Africa. The company also has exploration...

55 minutes ago

2 min read